Rh incompatibility during pregnancy is a well-understood blood type mismatch that can affect a baby’s health. The short answer is that Rh-negative blood types are the ones that can cause this issue when the mother is Rh-negative and the father is Rh-positive. This mismatch can trigger the mother’s immune system to attack the baby’s red blood cells in certain circumstances. Fortunately, routine medical care in the United States prevents almost all of the serious complications that used to occur from this condition.
What Blood Type Rejects Pregnancy Rh Incompatibility?
The blood type that “rejects” a pregnancy in Rh incompatibility is Rh-negative. This is not a rejection in the sense of organ transplant rejection. It is an immune response. If an Rh-negative mother carries an Rh-positive baby, her immune system may see the baby’s Rh-positive red blood cells as foreign. This can lead her body to produce antibodies against those cells.
Your blood type includes two main systems: the ABO system and the Rh system. The Rh system is simple. You are either Rh-positive or Rh-negative. Most people are Rh-positive. Being Rh-negative is not a disease and causes no health problems. The issue only arises during pregnancy when blood types are mismatched.
This condition only occurs when the mother is Rh-negative and the baby is Rh-positive. If both parents are Rh-negative, the baby will also be Rh-negative, and no incompatibility exists. If the mother is Rh-positive, the Rh factor is irrelevant because she already carries the antigen.
How Does Rh Incompatibility Actually Happen?
The problem begins when fetal red blood cells enter the mother’s bloodstream. This is called fetomaternal hemorrhage. It can happen during labor, delivery, miscarriage, abortion, or certain invasive prenatal tests like amniocentesis. Even a small amount of fetal blood can trigger the mother’s immune system if the blood types are incompatible.
Once exposed, the Rh-negative mother’s immune system treats the Rh-positive cells like an infection. It produces antibodies designed to destroy them. The first pregnancy is usually unaffected because antibody production takes time. By the time the mother has enough antibodies to matter, the baby is often already born.
The real danger appears in subsequent pregnancies. The mother’s immune system now remembers how to make these antibodies. In the next Rh-positive pregnancy, antibodies cross the placenta and attack the baby’s red blood cells. This causes hemolytic disease of the newborn, a condition where red blood cells are destroyed faster than the baby can replace them.
What Happens to the Baby During Rh Incompatibility?
When maternal antibodies destroy fetal red blood cells, the baby can develop anemia. Red blood cells carry oxygen. Without enough of them, the baby’s organs do not get the oxygen they need. The severity varies widely from mild anemia to a life-threatening condition called hydrops fetalis.
Hydrops fetalis is the most serious complication. The baby’s heart works harder to pump oxygen. Fluid builds up in the tissues and organs. Without treatment, this can be fatal. This condition is now rare in developed countries because prevention is so effective. Before prevention existed, Rh disease was a major cause of newborn death and disability.
Jaundice is another common effect. When red blood cells break down, they release bilirubin. The baby’s immature liver cannot process the excess bilirubin quickly. High bilirubin levels cause yellowing of the skin and eyes. In severe cases, bilirubin can accumulate in the brain and cause permanent neurological damage, a condition called kernicterus.
How Is Rh Incompatibility Prevented?
Prevention is straightforward and remarkably effective. Rh-negative mothers receive an injection of RhoGAM, a medication also known as Rh immune globulin. This medication contains antibodies against the Rh factor. It works by destroying any fetal Rh-positive cells in the mother’s bloodstream before her immune system can produce its own antibodies.
The injection is given at specific times. The first dose is typically administered around the 28th week of pregnancy. A second dose is given within 72 hours after birth if the baby is Rh-positive. The medication is also given after any event that might cause bleeding, such as miscarriage, abortion, ectopic pregnancy, or invasive procedures.
This treatment is standard of care in the United States and most developed countries. It has reduced the rate of Rh disease dramatically. Before RhoGAM was introduced in 1968, Rh disease affected about 10 percent of pregnancies where the mother was Rh-negative and father was Rh-positive. Today, cases are rare and almost always involve a missed dose or a lack of prenatal care.
What Tests Are Used to Detect Rh Incompatibility?
Blood type testing is routine at the first prenatal visit. Every pregnant woman has her blood type checked, including the Rh factor. This simple test tells your doctor immediately whether you are Rh-negative or Rh-positive. If you are Rh-negative, your doctor will also order an antibody screen.
The antibody screen checks whether you have already developed Rh antibodies. If the screen is negative, you have not been sensitized and prevention will work. If the screen is positive, you are already sensitized. This changes the management of your pregnancy completely. Your doctor will monitor the baby closely for anemia using ultrasound and other tests.
Fathers can also be tested. If the father is Rh-negative, the baby will be Rh-negative too, and no incompatibility exists. If the father is Rh-positive, there is a risk. However, if the father has one copy of the Rh gene, there is a 50 percent chance the baby will be Rh-negative. If he has two copies, the baby will definitely be Rh-positive. This information can help guide testing and planning.
What Happens If a Mother Is Already Sensitized?
Once a mother is sensitized, RhoGAM will not help. The immune system already has memory of the Rh antigen. Prevention is only possible before sensitization occurs. For sensitized mothers, treatment focuses on monitoring and supporting the baby.
Frequent ultrasounds track the baby’s blood flow. A measurement called the middle cerebral artery peak systolic velocity can detect anemia non-invasively. If anemia is moderate or severe, the baby may need an intrauterine transfusion. This procedure delivers donor red blood cells directly into the baby’s umbilical cord.
Intrauterine transfusions are highly specialized and performed at fetal medicine centers. They are effective but carry risks, including infection, bleeding, and premature labor. In some cases, early delivery is the best option. The decision depends on how severe the anemia is and how far along the pregnancy is.
How Common Is Rh-Negative Blood?
Rh-negative blood is relatively uncommon but not rare. About 15 percent of the United States population is Rh-negative. The prevalence varies by ethnicity. Approximately 15 percent of White people are Rh-negative. Only about 5 to 8 percent of Black people are Rh-negative. In Asian, Native American, and Pacific Islander populations, Rh-negative blood is very rare, occurring in less than 1 percent of people.
Because so many people are Rh-positive, the chance of an Rh-negative mother carrying an Rh-positive baby is significant. In a pregnancy where the mother is Rh-negative and the father is Rh-positive, the baby has about a 50 to 100 percent chance of being Rh-positive depending on the father’s genetics. This is why Rh screening is so important in prenatal care.
Frequently Asked Questions
Can Rh incompatibility affect a first pregnancy?
Usually not. The mother’s immune system takes time to produce antibodies, and the first baby is often born before this happens.
Is Rh incompatibility the same as a miscarriage?
No. Rh incompatibility itself does not cause miscarriage, but it can cause severe anemia in subsequent affected pregnancies if untreated.
Can an Rh-negative mother carry an Rh-positive baby safely?
Yes. With proper prenatal care and RhoGAM injections, the pregnancy is safe for both mother and baby.
Does Rh incompatibility affect the mother’s health?
No. The condition affects the baby only. The mother’s immune response does not harm her own body.
